account_balance
Investment manager · 13F filer · SEC CIK 1440771
Stonepine Capital Management, LLC
Reported value$168Mas of Jun 30, 2026
Positions82 27 new, 11 sold out
Top 10 weight50.3%VSTM alone is 8%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
VSTMVerastem Inc
7.6%
EOLSEvolus Inc
6.6%Trimmed −10%
AYTUAytu Biopharma Inc
5.7%Added +530%
TENXTenax Therapeutics Inc
5.7%Trimmed −32%
NKTRNektar Therapeutics
5.0%Added +42%
AZTRAzitra Inc
4.8%New
CNSPCNS Pharmaceuticals Inc
3.8%Added +2106%
ELOXEloxx Pharmaceuticals Inc
3.7%New
ADMAAdma Biologics Inc
3.7%
CAMPCamp4 Therapeutics Corp
3.6%
KZIAKazia Therapeutics Ltd
2.9%
SRZNSurrozen Inc
2.8%Added +106%
VSTMVerastem Inc
7.6%
EOLSEvolus Inc
6.6%Trimmed −10%
AYTUAytu Biopharma Inc
5.7%Added +530%
TENXTenax Therapeutics Inc
5.7%Trimmed −32%
NKTRNektar Therapeutics
5.0%Added +42%
AZTR4.8%CNSP3.8%ELOX3.7%ADMA3.7%CAMP3.6%KZIA2.9%SRZN2.8%Boxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
VSTM Verastem Inc 7.6% HeldEOLS Evolus Inc 6.6% Trimmed −10%AYTU Aytu Biopharma Inc 5.7% Added +530%TENX Tenax Therapeutics Inc 5.7% Trimmed −32%NKTR Nektar Therapeutics 5.0% Added +42%AZTR Azitra Inc 4.8% NewCNSP CNS Pharmaceuticals Inc 3.8% Added +2106%ELOX Eloxx Pharmaceuticals Inc 3.7% NewADMA Adma Biologics Inc 3.7% HeldCAMP Camp4 Therapeutics Corp 3.6% HeldKZIA Kazia Therapeutics Ltd 2.9% HeldSRZN Surrozen Inc 2.8% Added +106%
What changed